logo

For the Inventor, By the Inventor

Menlo Park, CA, United States of America

Chimera Bioengineering, Inc.


USPTO Granted Patents = 21

% Expired Patents = 19.0


Forward Citations = 63

Loading Chart...
Loading Chart...

6 inventors (with patents filed for the assignee):

goldMedal Benjamin Wang (21 out of 26 patents)

silverMedal Gusti Zeiner (21 out of 29 patents)

bronzeMedal Krista McNally (5 out of 5 patents)

4.  Scott Dylla (1 out of 1 patent)

5.  Eytan Herzig (1 out of 1 patent)

6.  Albert Gacerez (1 out of 1 patent)

7.  Benjamin Wang (0 patent)


21 patents:

1. 12576135 - Compositions and Methods for Anti-TnMUC1 Gold CAR T-cells (2026-03-17),
2. 11718929 - Methods for making novel antigen binding domains (2023-08-08),
3. 11648277 - Combination therapy with gold controlled transgenes (2023-05-16),
4. 11572566 - Gold optimized CAR t-cells (2023-02-07),
5. 11535853 - Gold optimized CAR T-cells (2022-12-27),
6. 11530272 - Smart car devices, DE car polypeptides, side CARs and uses thereof (2022-12-20),
7. 11497774 - Coordinating gene expression using RNA destabilizing elements (2022-11-15),
8. 11459572 - Gold optimized CAR T-cells (2022-10-04),
9. 11311577 - Coordinating gene expression using RNA destabilizing elements (2022-04-26),
10. 11110125 - Coordinating gene expression using RNA destabilizing elements (2021-09-07),
11. 11085917 - Methods for making novel antigen binding domains (2021-08-10),
12. 11052111 - Smart CAR devices and DE CAR polypeptides for treating disease and methods for enhancing immune responses (2021-07-06),
13. 10858660 - Gold optimized CAR T-cells (2020-12-08),
14. 10688132 - Coordinating gene expression using RNA destabilizing elements (2020-06-23),
15. 10675305 - Coordinating gene expression using RNA destabilizing elements (2020-06-09),
Company Overview
Chimera Bioengineering, Inc. is a biotechnology company based in Menlo Park, California, specializing in the development of advanced cellular therapies and bioengineering solutions. The organization focuses on harnessing the power of synthetic biology to create innovative treatments for a range of medical conditions. By leveraging cutting-edge research in genetic engineering and cell manipulation, Chimera aims to transform therapeutic approaches and improve patient outcomes in the evolving landscape of healthcare.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

21 Patents

#76 in Menlo Park, CA

#3,755 in California

#15,681 in US

#29,928 in the World

Menlo Park, CA (US)
Menlo Park, CA, United States of America

Chimera Bioengineering, Inc.

Forward Citations = 63

6 inventors:

goldMedal Benjamin Wang (21 out of 26 patents)

silverMedal Gusti Zeiner (21 out of 29 patents)

bronzeMedal Krista McNally (5 out of 5 patents)

4.  Scott Dylla (1 out of 1 patent)

5.  Eytan Herzig (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Chimera Bioengineering, Inc.. Retrieved from https://idiyas.com/company/chimera-bioengineering

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…